new
viral
pneumonia
diseas
outbreak
wuhan
citi
begin
confirm
caus
novel
coronaviru
infect
previous
found
human
bodi
previou
case
pneumonia
detect
primari
clinic
symptom
infect
coronaviru
chill
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
accord
report
wuhan
citi
main
epidem
area
peopl
infect
often
symptom
fever
cough
short
breath
dyspnea
sever
infect
lead
pneumonia
even
death
epidem
spread
main
epidem
area
hubei
provinc
wuhan
citi
provinc
citi
new
success
case
infect
report
citi
wenzhou
citi
zhejiang
provinc
epidem
situat
seriou
therefor
locat
outsid
main
epidem
area
design
secondari
epidem
area
studi
first
cluster
case
infect
wenzhou
citi
zhejiang
provinc
lead
secondari
epidem
area
report
note
secondari
epidem
area
refer
new
area
experienc
epidem
caus
arriv
infect
patient
main
epidem
area
diseas
spread
similar
main
epidem
area
hubei
provinc
wuhan
citi
clinic
data
patient
diagnos
novel
coronaviru
posit
nucleic
acid
test
sputum
throat
swab
lower
respiratori
secret
sampl
collect
januari
februari
patient
gave
sign
inform
consent
date
use
scientif
research
ethic
approv
studi
obtain
second
affili
hospit
wenzhou
medic
univers
zhejiang
china
inclus
criteria
patient
age
year
older
met
ncp
diagnost
criteria
includ
exclus
criteria
patient
infecti
respiratori
diseas
patient
suspect
multipl
neg
sputum
throat
swab
lower
respiratori
secret
sampl
exclud
group
method
accord
previou
histori
patient
met
infect
diagnost
criteria
case
occur
return
wenzhou
wuhan
assign
direct
contact
dc
group
histori
resid
wuhan
main
epidem
area
onset
diseas
assign
indirect
contact
idc
group
clinic
test
indic
symptom
fever
cough
fatigu
sore
time
examin
result
test
compar
two
group
statist
method
sa
statist
analysi
softwar
use
ttest
use
comparison
group
continu
variabl
comparison
group
categor
variabl
perform
use
fisher
exact
probabl
method
mean
standard
deviat
use
describ
central
discret
trend
ttest
ranksum
test
fisher
exact
probabl
method
use
comparison
group
indic
differ
statist
signific
accord
descript
basic
symptom
sign
total
studi
popul
data
conform
case
includ
male
femal
analyz
dc
group
contain
patient
nine
male
six
femal
averag
age
year
idc
group
patient
eight
male
ten
femal
averag
age
year
dc
group
patient
hypertens
patient
hyperglycemia
patient
hyperlipemia
idc
group
patient
hypertens
patient
hyperglycemia
patient
hyperlipemia
dc
group
averag
bodi
temperatur
case
fever
case
sore
throat
case
cough
case
cough
case
nasal
congest
case
fatigu
case
muscl
sore
idc
group
averag
bodi
temperatur
fever
case
sore
throat
case
cough
case
product
cough
case
nasal
congest
case
fatigu
case
muscl
sore
case
signific
differ
group
see
tabl
data
nausea
vomit
respiratori
distress
chest
pain
comparison
blood
test
result
creactiv
protein
crp
test
result
two
group
show
averag
white
blood
cell
count
dc
group
l
neutrophil
count
l
lymphocyt
count
l
monocyt
count
l
eosinophil
count
l
eosinophil
basic
granulocyt
count
l
hemoglobin
hb
gl
red
blood
cell
count
l
platelet
plt
count
l
creactiv
protein
crp
mgl
idc
group
averag
white
blood
cell
count
l
neutrophil
count
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
l
monocyt
count
l
eosinophil
count
l
eosinophil
basic
granulocyt
count
l
hemoglobin
hb
gl
red
blood
cell
count
l
platelet
plt
count
l
creactiv
protein
crp
mg
l
neutrophil
ratio
data
shown
tabl
serum
amyloid
protein
saa
test
among
patient
enrol
studi
patient
dc
group
test
serum
amyloid
protein
saa
found
saa
patient
increas
significantli
averag
valu
mgl
normal
valu
mgl
increas
protein
obviou
increas
crp
due
limit
data
compar
statist
analysi
perform
futur
focu
saa
ncp
patient
see
tabl
detail
data
comparison
blood
cell
count
creactiv
protein
crp
ratio
dc
group
leukocyt
countcreact
protein
monocyt
ratiocreact
protein
neutrophil
countcreact
protein
monocyt
countcreact
protein
hemoglobincreact
protein
valu
respect
idc
group
leukocyt
countcreact
protein
monocyt
ratiocreact
protein
neutrophil
countcreact
protein
monocyt
countcreact
protein
hemoglobincreact
protein
valu
respect
differ
blood
cell
count
creactiv
protein
ratio
two
group
statist
signific
p
see
tabl
detail
data
accord
report
scholar
main
epidem
area
primari
clinic
symptom
patient
fever
dri
cough
fatigu
gradual
develop
respiratori
problem
fever
typic
patient
present
obviou
upper
respiratori
symptom
eg
runni
nose
sneez
sore
throat
diarrhea
headach
hemoptysi
rare
patient
mild
infect
may
show
slight
fatigu
fever
critic
ill
patient
may
develop
symptom
acut
respiratori
distress
syndrom
septic
shock
metabol
acidosi
coagul
dysfunct
addit
symptom
short
breath
audibl
wet
sound
lung
weak
breath
sound
dull
percuss
tactil
tremor
may
increas
decreas
studi
found
clinic
symptom
patient
secondari
epidem
area
similar
patient
primari
epidem
area
inconsist
secondari
epidem
area
main
symptom
fever
mainli
moderateto
lowgrad
fever
cough
usual
dri
often
accompani
white
phlegm
fatigu
muscl
ach
seen
patient
symptom
upper
respiratori
tract
infect
sneez
runni
nose
sore
throat
itch
uncommon
symptom
chest
distress
chest
pain
less
common
secondari
epidem
area
main
epidem
area
may
relat
rapid
diagnosi
secondari
epidem
area
earli
treatment
intervent
moreov
critic
patient
rare
may
relat
younger
age
patient
presenc
fewer
complic
secondari
epidem
area
main
epidem
area
accord
report
main
epidem
area
patient
limit
lung
lesion
earli
stage
onset
ct
show
multipl
lesion
rare
singl
lesion
lung
ct
find
appear
local
small
patch
subseg
larg
ground
glass
shadow
local
leaflet
wide
space
without
thicken
progress
ct
show
increas
lesion
expand
lesion
multipl
lung
lobe
involv
densiti
lesion
increas
irregular
wedgeshap
fanshap
consolid
vari
size
degre
within
lesion
appear
mutat
shadow
strip
shadow
coexist
diffus
lung
lesion
seen
ct
sever
patient
consolid
primari
caus
addit
ground
glass
shadow
multipl
fiber
strand
shadow
sever
case
white
lung
manifest
appear
lung
affect
air
bronchu
sign
present
result
imag
examin
patient
secondari
epidem
area
collect
studi
similar
report
main
epidem
area
explan
given
articl
patient
infect
diagnos
main
epidem
area
laboratori
examin
result
earli
stage
diseas
show
total
number
white
blood
cell
decreas
remain
normal
lymphocyt
count
decreas
monocyt
count
increas
remain
normal
liver
enzym
muscl
enzym
myoglobin
level
increas
patient
creactiv
protein
esr
increas
patient
procalcitonin
remain
normal
ddimer
increas
sever
patient
lymphocyt
progress
decreas
coagul
function
decreas
inflammatori
cytokin
tumor
necrosi
remain
normal
slightli
increas
level
cytokin
patient
organ
failur
significantli
increas
addit
coronaviru
nucleic
acid
detect
throat
swab
sputum
sampl
lower
respiratori
secret
blood
sampl
among
infect
patient
viral
load
detect
secret
lower
respiratori
tract
higher
detect
upper
respiratori
tract
laboratori
examin
result
patient
show
total
number
leukocyt
patient
infect
secondari
epidem
area
slightli
reduc
normal
slightli
increas
proport
lymphocyt
patient
significantli
reduc
rare
lymphocyt
neutrophil
increas
monocyt
eosinophil
acidbas
granulocyt
chang
significantli
crp
chang
significantli
patient
infect
patient
maintain
normal
crp
level
found
serum
amyloid
saa
increas
significantli
patient
test
howev
due
limit
amount
data
statist
analysi
perform
saa
acutephas
protein
saa
significantli
increas
viral
infect
wherea
crp
may
increas
slightli
increas
viral
infect
without
bacteri
infect
moreov
saa
increas
viral
bacteri
infect
increas
reflect
sever
infect
present
gener
agre
saa
crp
combin
judg
inflammatori
activ
consid
secondari
epidem
area
may
occur
primari
epidem
main
epidem
area
toxic
pathogen
may
weaken
saa
detect
secondari
epidem
area
consid
evalu
occurr
develop
infect
focu
detect
saa
peopl
followup
studi
signific
differ
ratio
variou
blood
paramet
crp
two
group
interest
find
studi
report
crp
may
increas
slightli
increas
viral
infect
without
bacteri
infect
increas
indirectli
reflect
sever
infect
present
gener
accept
crp
combin
crp
use
judg
inflammatori
activ
studi
found
ratio
variou
blood
paramet
crp
significantli
increas
patient
indirect
contact
diseas
epidem
area
suggest
chang
reactiv
crp
infect
greater
respons
variou
blood
paramet
addit
consid
secondari
epidem
area
may
occur
primari
epidem
main
epidem
area
toxic
pathogen
may
weaken
crp
use
predict
factor
prior
chang
leukocyt
lymphocyt
neutrophil
inflammatoryrel
blood
paramet
comprehens
evalu
occurr
develop
infect
fund
support
project
author
contribut
manuscript
design
complet
weip
ji
gautam
bishnu
complet
data
languag
work
zhenzhai
cai
complet
statist
verif
xian
shen
complet
review
revis
paper
guid
whole
process
